Ondansetron and Potassium phosphates drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ondansetron (ondansetron) and Potassium phosphates (potassium phosphate, dibasic; potassium phosphate, monobasic). Common drug interactions include memory impairment among females and bronchopulmonary aspergillosis among males.

The phase IV clinical study analyzes what interactions people have when they take Ondansetron and Potassium phosphates. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Ondansetron?

Ondansetron has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 122,738 Ondansetron users. Check the latest studies of Ondansetron.

What is Potassium phosphates?

Potassium phosphates has active ingredients of potassium phosphate, dibasic; potassium phosphate, monobasic. eHealthMe is studying from 159 Potassium phosphates users. Check the latest studies of Potassium phosphates.

On Jul, 31, 2026

50 people who take Ondansetron and Potassium phosphates together, and have interactions are studied.

Ondansetron and Potassium phosphates drug interactions.

What are the common drug interactions of Ondansetron and Potassium Phosphates, by gender? *:

female:

Memory impairment
Neuropathy peripheral (surface nerve damage)
Obstruction
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pulmonary sepsis (pus in lungs)
Rash
Sepsis (a severe blood infection that can lead to organ failure and death)
Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
Weight decreased
Acidosis (build-up of carbon dioxide in the blood)

male:

Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Confusional state
Respiratory failure (inadequate gas exchange by the respiratory system)
Acute myocardial infarction (acute heart attack)
Agitation (state of anxiety or nervous excitement)
Aphasia (damage to the parts of the brain that control language)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood phosphorus decreased
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)

What are the common drug interactions of Ondansetron and Potassium Phosphates, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)
Respiratory failure (inadequate gas exchange by the respiratory system)

20-29:

Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
Brain death
Brain injury
Cardiac arrest
Electrocardiogram qt prolonged
Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)
Myocardial reperfusion injury (tissue damage of heart muscle caused when blood supply returns to the tissue after a period of ischemia or lack of oxygen)
Pneumonia
Pulmonary embolism (blockage of the main artery of the lung)
Ventricular fibrillation (abnormally irregular heart rhythm)

30-39:

Disease progression

40-49:

Adverse event

50-59:

Renal failure (kidney dysfunction)
Bacterial sepsis
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Diarrhoea
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Dehydration (dryness resulting from the removal of water)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Acute respiratory failure
Aphasia (damage to the parts of the brain that control language)

60+:

Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Sepsis (a severe blood infection that can lead to organ failure and death)
Alanine aminotransferase increased
Anaemia (lack of blood)
Hypoxia (low oxygen in tissues)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Benign prostatic hyperplasia (benign enlargement of the prostate)
Anxiety
Aspartate aminotransferase increased

What are the existing conditions these people have? *

Constipation: 7 people, 14.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 7 people, 14.00%
Sedation: 6 people, 12.00%
Pain: 6 people, 12.00%
Nausea And Vomiting: 5 people, 10.00%
Hypotension (abnormally low blood pressure): 5 people, 10.00%
Hypokalemia (low potassium): 5 people, 10.00%
High Blood Pressure: 5 people, 10.00%
Adverse Event: 5 people, 10.00%
Back Pain: 5 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ondansetron and Potassium phosphates?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously